That sounds like a reasonable scenerio. If that is the case does anyone have any ideas on how much more they might need to dilute to get there? Also, if the non stop dilution continues surely we will see much lower prices even. Is it really possible we could uplist to the Nasdaq below $1.00 when that is there threshold for delisting stocks that are already on there? How do we get around that?
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links